AC Immune reports positive week-100 data for Parkinson's vaccine trial
Tweet Send to a Friend
AC Immune SA (NASDAQ: ACIU) announced positive safety and immunogenicity results through week-100 in Part 1 of VacSYn, a randomized ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
